RRoche Read More Roche signs drug-discovery deal with Atavistik Bio worth up to $2 billion2026-10-23 Sept 24 (Reuters) – Drug developer Atavistik Bio said on Thursday it has signed a deal with Swiss…
RRoche Read More Roche signs drug-discovery deal with Atavistik Bio worth up to $2 billion2026-09-24 Sept 24 (Reuters) – Drug developer Atavistik Bio said on Thursday it has signed a deal with Swiss…
NNovartis Read More SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer’s Disease2026-03-15 ROCKVILLE, Md. , Jan. 12, 2026 /PRNewswire/ — SciNeuro Pharmaceuticals Logo (PRNewsfoto/SciNeuro Pharmaceuticals) SciNeuro grants Novartis an exclusive worldwide…